• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由血小板定义的非HLA-D/DR决定簇EP1引起的原发性混合淋巴细胞反应中的刺激。

Stimulation in primary MLR caused by a PLT defined non-HLA-D/DR determinant, EP1.

作者信息

Holter W, Morling N

出版信息

Tissue Antigens. 1983 Jul;22(1):42-8. doi: 10.1111/j.1399-0039.1983.tb01164.x.

DOI:10.1111/j.1399-0039.1983.tb01164.x
PMID:6193606
Abstract

The influence in primary mixed lymphocyte culture reaction (MLR) of a primed lymphocyte typing (PLT) defined non-HLA-D/DR determinant, EP1, was investigated. In primary MLR between HLA-D/DR compatible lymphocytes, the response of the lymphocytes from 14 EP1-negative HLA-D/DR heterozygous individuals towards two EP1-positive homozygous typing cells (HTCs) was on an average approximately 35% higher than the response towards two EP1-negative HTCs (P less than 0.01). The strength of the MLR between lymphocytes from 25 EP1-negative and 10 EP1-positive individuals matched for two HLA-D/DR antigens was investigated. The average responses of EP1-negative lymphocytes against EP1-positive lymphocytes were approximately 40% higher than the average responses against EP1-negative lymphocytes (P less than 0.01). These data indicate that the PLT defined determinant EP1 causes stimulation in primary MLR.

摘要

研究了由混合淋巴细胞分型(PLT)定义的非HLA - D/DR决定簇EP1对初次混合淋巴细胞培养反应(MLR)的影响。在HLA - D/DR相容淋巴细胞之间的初次MLR中,14名EP1阴性的HLA - D/DR杂合个体的淋巴细胞对两个EP1阳性纯合分型细胞(HTC)的反应平均比对两个EP1阴性HTC的反应高约35%(P小于0.01)。研究了25名EP1阴性和10名EP1阳性个体的淋巴细胞之间的MLR强度,这两组个体在两个HLA - D/DR抗原上相匹配。EP1阴性淋巴细胞对EP1阳性淋巴细胞的平均反应比对EP1阴性淋巴细胞的平均反应高约40%(P小于0.01)。这些数据表明,由PLT定义的决定簇EP1在初次MLR中引起刺激作用。

相似文献

1
Stimulation in primary MLR caused by a PLT defined non-HLA-D/DR determinant, EP1.由血小板定义的非HLA-D/DR决定簇EP1引起的原发性混合淋巴细胞反应中的刺激。
Tissue Antigens. 1983 Jul;22(1):42-8. doi: 10.1111/j.1399-0039.1983.tb01164.x.
2
[Lymphocyte stimulation in the primed lymphocyte typing test by as yet unknown HLA-linked antigens (WP-alleles)].[在预致敏淋巴细胞分型试验中由尚未明确的HLA连锁抗原(WP等位基因)引起的淋巴细胞刺激]
Wien Klin Wochenschr. 1983 Sep 30;95(18):643-5.
3
Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.同种反应性淋巴细胞克隆的血小板特异性与HLA - DR、MB和MT决定簇的关联。
Immunogenetics. 1982;16(3):209-18. doi: 10.1007/BF00343310.
4
Typing for human alloantigens with the primed lymphocyte typing (PLT) technique with notes on the interpretation of PLT data.用预处理淋巴细胞分型(PLT)技术对人类同种异体抗原进行分型及PLT数据解读注释
Hum Immunol. 1981 Jul;2(4):333-40. doi: 10.1016/0198-8859(81)90035-5.
5
The role of primary MLC of the non HLA-D/DR determinant PL3A.非HLA-D/DR决定簇PL3A的主要混合淋巴细胞培养的作用。
Tissue Antigens. 1981 Jan;17(1):57-63. doi: 10.1111/j.1399-0039.1981.tb00666.x.
6
AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.可溶性 HLA - DR 抗原体外激活的人 T 淋巴细胞的 AMLR 和 MLR 刺激活性。
Clin Exp Immunol. 1986 Jan;63(1):163-70.
7
Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).通过启动淋巴细胞分型(PLT)检测到的HLA-D/DR区域内重组。
Tissue Antigens. 1983 Aug;22(2):123-33. doi: 10.1111/j.1399-0039.1983.tb01178.x.
8
Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.自体混合淋巴细胞反应中肺泡巨噬细胞对T细胞增殖的刺激作用。HLA - DR抗原的作用。
Am Rev Respir Dis. 1986 Jan;133(1):78-82. doi: 10.1164/arrd.1986.133.1.78.
9
The influence of matching for SB on MLC typing is significant but marginal.对供体特异性抗体(SB)进行匹配对混合淋巴细胞培养(MLC)分型的影响显著但很微小。
Scand J Immunol. 1984 Mar;19(3):265-8. doi: 10.1111/j.1365-3083.1984.tb00928.x.
10
Lack of shared lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed lymphocyte typing cells.利用小鼠致敏淋巴细胞分型细胞检测发现,H-2I与HLA-D/DR之间缺乏共同的淋巴细胞刺激决定簇。
Hum Immunol. 1983 Jun;7(2):105-15. doi: 10.1016/s0198-8859(83)80011-1.